Vitamin D deficiency, CD4+CD28null cells and Accelerated Atherosclerosis in Chronic Kidney Disease
Yadav AK et al. - Vitamin D deficiency, inflammatory activation and higher frequency of CD4+CD28null T lymphocyte population correlate with preclinical atherosclerotic changes in chronic kidney disease (CKD) population. These findings suggest possible linkage between vitamin D metabolism and T cell modulation, abnormalities which may contribution to development of atherosclerosis in CKD.
A total of of 101 stage 4-5 non-dialysis CKD patients and 40 healthy controls were studied.
Common carotid artery intima media thickness (CCA-IMT) was measured with an ultrasound system.
25(OH) vitamin D and highly sensitive C-reactive protein (hsCRP) were measured in serum by ELISA.
The frequency of circulating CD4+CD28null cells was evaluated by flowcytometry.
CKD subjects exhibited higher CCA-IMT (0.71±0.01 v 0.56±0.01 mm, p<0.0001), hsCRP (90.7±5.8 v 50.1±8.6 µg/ml, p<0.0001), CD4+CD28null cell frequency (9.1±0.9 v 3.6±0.5%, p<0.0001) and lower 25(OH) vitamin D levels (17.9±1.9 v 26.9±3.5 ng/ml, p<0.0001).
In CKD subjects, serum 25 (OH) vitamin D level showed a strong inverse correlation with CCA-IMT (r=-0.729, p<0.0001), and correlated with CD4+CD28null cell frequency (r=-0.249, p=0.01) and hsCRP (r=-0.2, p=0.047).
The authors also noted correlation of IMT with patient age (r=0.291, p=0.004) and CD4+CD28null cells (r=0.34, p=0.001).
On multiple regression analysis, 25(OH) vitamin D level, diabetic status and CD4+CD28null cell frequency exhibited independent association with IMT in CKD subjects.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.